Cargando…
LRFN5 and OLFM4 as novel potential biomarkers for major depressive disorder: a pilot study
Evidences have shown that both LRFN5 and OLFM4 can regulate neural development and synaptic function. Recent genome-wide association studies on major depressive disorder (MDD) have implicated LRFN5 and OLFM4, but their expressions and roles in MDD are still completely unclear. Here, we examined seru...
Autores principales: | Xu, Ke, Zheng, Peng, Zhao, Shuang, Wang, Jiubing, Feng, Jinzhou, Ren, Yi, Zhong, Qi, Zhang, Hanping, Chen, Xiangyu, Chen, Jianjun, Xie, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244395/ https://www.ncbi.nlm.nih.gov/pubmed/37280213 http://dx.doi.org/10.1038/s41398-023-02490-7 |
Ejemplares similares
-
SALM/Lrfn Family Synaptic Adhesion Molecules
por: Lie, Eunkyung, et al.
Publicado: (2018) -
MANF/EWSR1/ANXA6 pathway might as the bridge between hypolipidemia and major depressive disorder
por: Xu, Ke, et al.
Publicado: (2022) -
New Insights of OLFM2 and OLFM4 in Gut-Liver Axis and Their Potential Involvement in Nonalcoholic Fatty Liver Disease
por: Bertran, Laia, et al.
Publicado: (2022) -
A Prognostic Signature Constructed by CTHRC1 and LRFN4 in Stomach Adenocarcinoma
por: Han, Songling, et al.
Publicado: (2021) -
Significance of differential expression of OLFM4 in the development of endometrial adenocarcinoma
por: Huang, Di, et al.
Publicado: (2022)